Literature DB >> 27965918

Minimally Invasive Cardiac Surgery versus Conventional Median Sternotomy for Atrial Septal Defect Closure.

Joon Chul Jung1, Kyung-Hwan Kim1.   

Abstract

BACKGROUND: Median sternotomy is the standard approach for atrial septal defect (ASD) closure. However, minimally invasive cardiac surgery (MICS) has been introduced at many centers in adult/grown-up congenital heart patients. We retrospectively reviewed the results of right anterolateral thoracotomy compared with conventional median sternotomy (CMS) for ASD closure at Seoul National University Hospital.
METHODS: We retrospectively analyzed 60 adult patients who underwent isolated ASD closure from January 2004 to December 2013 (42 in the CMS group, 18 in the MICS group). Preoperative, operative, and postoperative data were collected and compared between the 2 groups.
RESULTS: The MICS group was younger (44.6 years vs. 32.4 years, p=0.002) and included more females (66.7% vs. 94.4%, p=0.025) than the CMS group. Operation time (188.4 minutes vs. 286.7 minutes, p<0.001), cardiopulmonary bypass time (72.7 minutes vs. 125.8 minutes, p<0.001), and aortic cross-clamp time (25.5 minutes vs. 45.6 minutes, p<0.001) were significantly longer in the MICS group. However, there were no significant differences in morbidity and mortality between groups. Only chest tube drainage in the first 24 hours (627.1 mL vs. 306.1 mL, p<0.001) exhibited a significant difference.
CONCLUSION: MICS via right anterolateral thoracotomy is an alternative choice for ASD closure. The results demonstrated similar morbidity and mortality between groups, and favored MICS in chest tube drainage in the first 24 hours.

Entities:  

Keywords:  Atrial heart septal defects; Congenital heart disease; Minimally invasive surgery; Sternotomy

Year:  2016        PMID: 27965918      PMCID: PMC5147466          DOI: 10.5090/kjtcs.2016.49.6.421

Source DB:  PubMed          Journal:  Korean J Thorac Cardiovasc Surg        ISSN: 2233-601X


Introduction

Atrial septal defect (ASD) is a common congenital heart disease with an incidence of 900 per million in the United States [1], and surgical results of ASD closure are favorable [2]. Most patients are diagnosed in childhood, but some patients are diagnosed as adults. Seoul National University Hospital has a separate children’s hospital, but ASD patients over 15 years old generally visit and undergo surgery at the adult cardiac center. Median full sternotomy is the standard approach for surgical ASD closure in children and adults. The ASD closure procedure is relatively simple compared to other complex congenital and adult heart diseases, and more people are concerned about cosmetic outcomes. Therefore, minimally invasive cardiac surgery (MICS) for ASD closure has been introduced at many centers. Our center has used right anterolateral thoracotomy for ASD closure in adult patients for the past 10 years. This study retrospectively reviewed the results of right anterolateral thoracotomy for ASD closure and compared the outcomes with conventional median sternotomy (CMS).

Methods

A total of 125 consecutive patients over 15 years old underwent ASD closure at our institution by a single surgeon from January 2004 to December 2013. Patients who underwent concomitant procedures, such as the Maze procedure, mitral valve annuloplasty, and tricuspid valve annuloplasty, were excluded. Sixty patients with isolated ASD closure constituted the final study population. The age of the patients was between 16 and 73 years. CMS was performed in 42 patients, and MICS was performed in 18 patients. Preoperative, operative, and postoperative data were collected from patients’ medical records and compared between the 2 groups. This study was approved by the institutional review board of Seoul National University Hospital (1507-007-683). In the CMS group, standard median sternotomy was performed, and the usual aortic and bi-caval cannulations were used. Cardioplegia was infused in an antegrade manner via the aortic root cannula, and the ascending aorta was cross-clamped. The right atrium was opened, and the ASD was closed with glutaraldehyde-fixed auto-pericardium. Patients in the MICS group were positioned with their right side up by inserting towels under the right back. A small incision (approximately 2–3 cm) was made in the inguinal region for femoral artery and vein development. A purse string suture was applied at the common femoral vein, and a venous cannula was inserted and the tip positioned at the inferior vena cava (IVC) level under trans-esophageal echocardiography guidance. Another venous cannula was inserted via the internal jugular vein and positioned at the superior vena cava (SVC) level. Internal jugular vein cannulation was aided by ultrasonography-guided puncture in the operative field. Two venous cannulae were connected with a Y-connector. A purse string suture was applied at the common femoral artery, and an arterial cannula was inserted (Fig. 1A). A small anterolateral thoracotomy (approximately 6–8 cm) was made at the sub-mammary line, and the pleural cavity was entered through the fourth intercostal space (Fig. 1B). The pericardium was opened and retracted using a suture that passed through the chest wall via separate incision. The SVC and IVC were snared down with umbilical tape and a slider after cardiopulmonary bypass (CPB) was initiated. Aortic cross-clamp (ACC) was achieved using a Chitwood DeBakey Clamp (Scanlan International Inc., St. Paul, MN, USA) through a separate incision at the second intercostal space. Cardioplegia was infused in an antegrade manner via the aortic root cannula. The right atrium was opened, and the ASD was closed using glutaraldehyde-fixed auto-pericardium. During the entire procedure, CO2 gas was infused into the chest wall to reduce the risk of air embolism. No thoracoscopy or thoracoscopic devices were used. The right atrium was closed, the ACC was released, and CPB weaning and decannulation procedures were performed using standard techniques. Thoracotomy and femoral wounds were closed with special concern for cosmetics.
Fig. 1

(A) Femoral artery and vein cannulations are performed. (B) Right internal jugular vein cannulation and right anterolateral thoracotomy are performed.

Categorical variables are described using frequency and percentage. Continuous variables are described as the means and standard deviation. Comparisons of categorical variables between 2 groups were performed using the chi-square or the Fisher exact test. Comparisons of continuous variables were performed using the Student t-test or Mann-Whitney U-test after pretests for normal distribution. Statistical significance was accepted when the p-value was <0.05.

Results

The MICS group was younger (44.6±13.8 years vs. 32.4±11.3 years, p=0.002) and included more females (28 [66.7%] vs. 17 [94.4%], p=0.025) than the CMS croup. However, preoperative ejection fraction and underlying diseases were not significantly different between the 2 groups (Table 1).
Table 1

Preoperative patient characteristics

CharacteristicConventional median sternotomy (n=42)Minimally invasive cardiac surgery (n=18)p-value
Sex (female)28 (66.7)17 (94.4)0.025
Age (yr)44.6±13.832.4±11.30.002
Body mass index (kg/m2)21.9±2.521.7±3.10.787
Ejection fraction (%)58.4±6.860.1±5.40.309
Hypertension8 (19.0)1 (5.6)0.255
Diabetes mellitus1 (2.4)0>0.99
Coronary artery disease00
Chronic obstructive pulmonary disease1 (2.4)0>0.99
Congestive heart failure00
Transient ischemic attack00
Stroke00
Peripheral vascular disease00
Renal failure2 (4.8)0>0.99
Arrhythmia1 (2.4)0>0.99

Values are presented as number (%) or mean±standard deviation.

The operation time (188.4±37.8 minutes vs. 286.7± 30.8 minutes, p<0.001), CPB time (72.7±21.5 minutes vs. 125.8±17.8 minutes, p<0.001), and ACC time (25.5±9.8 minutes vs. 45.6±9.4 minutes, p<0.001) were significantly longer in the MICS group. The rectal temperature (32.0°C±1.6°C vs. 27.8°C±1.8°C, p<0.001) and nasopharyngeal temperature (30.0°C±2.1°C vs. 25.4°C±2.0°C, p<0.001) were significantly lower in the MICS group. There were no significant differences in intraoperative transfusion (Table 2).
Table 2

Operative details

VariableConventional median sternotomy (n=42)Minimally invasive cardiac surgery (n=18)p-value
Operation time (min)188.4±37.8286.7±30.8<0.001
Cardiopulmonary bypass time (min)72.7±21.5125.8±17.8<0.001
Aortic cross-clamp time time (min)25.5±9.845.6±9.4<0.001
Lowest rectal temperature (°C)32.0±1.627.8±1.8<0.001
Lowest nasopharyngeal temperature (°C)30.0±2.125.4±2.0<0.001
Intraoperative transfusion9 (21.4)1 (5.6)0.256
Intraoperatively infused blood products (mL)128.6±312.413.9±59.00.114

Values are presented as mean±standard deviation or number (%).

There were no significant differences in morbidities and mortalities between groups. Mechanical ventilation time (14.6±12.2 hours vs. 12.2±7.1 hours, p=0.566), intensive care unit length of stay (LOS) (37.5±37.1 hours vs. 27.4±11.7 hours, p=0.675), and hospital LOS (7.3±10.9 days vs. 5.9±1.9 days, p=0.746) were shorter in the MICS group, but these differences were not statistically significant. Postoperative transfusion was also not significantly different. Only chest tube drainage in the first 24 hours (627.1±742.6 mL vs. 306.1±354.2 mL, p<0.001) was significantly different. There were no residual shunts or early or late re-interventions in the 2 groups (Table 3).
Table 3

Postoperative results

VariableConventional median sternotomy (n=42)Minimally invasive cardiac surgery (n=18)p-value
Conversion to sternotomy0
In-hospital mortality1 (2.4)0>0.99
Reoperation for bleeding2 (4.8)0>0.99
Cardiac arrest00
Neurological complication00
Respiratory failure00
Postoperative intra-aortic balloon pump insertion00
Myocardial infarction00
Atrial fibrillation8 (19.0)1 (5.6)0.255
Renal failure1 (2.4)0>0.99
Wound complication1 (2.4)0>0.99
Complication of femoral cannulation0
Mechanical ventilation time (hr)14.6±12.212.2±7.10.566
Intensive care unit LOS (hr)37.5±37.127.4±11.70.675
Hospital LOS (day)7.3±10.95.9±1.90.746
Chest tube drainage in first 24 hours (mL)627.1±742.6306.1±354.2<0.001
Blood product requirement8 (19.0)4 (22.2)0.740
Postoperatively infused red blood cell (mL)196.4±598.683.3±257.20.471
Postoperatively infused total blood products (mL)367.9±1,226.5183.9±559.60.889
Residual defect00
Early re-intervention00
Late re-intervention00

Values are presented as number (%) or mean±standard deviation.

LOS, length of stay.

Discussion

Several methods of MICS for ASD closure have been reported, including partial sternotomy, right parasternal mini-incision, right anterolateral thoracotomy, right posterolateral thoracotomy, video-assisted mini-thoracotomy, robot-assisted surgery, and total thoracoscopic surgery without robotic assistance [3-11]. MICS exhibits a cosmetic advantage. However, MICS has the disadvantages of a restricted operative field and technical difficulties in peripheral cannulation and aortic cross-clamping. Therefore, MICS should exhibit similar outcomes as conventional median sternotomy. Several studies of MICS for ASD closure have been performed, and most results have revealed comparable outcomes between the 2 groups [12-15]. Right anterolateral thoracotomy has the advantage of providing a direct field of vision to the right atrium, which may be incised and approached for ASD. Therefore, the skin incision is minimized and adjusted to the size required for ASD closure. The incision may be entirely hidden in the innerwear line. Our results revealed that the MICS group experienced significantly longer operation times, CPB times, and ACC times, primarily because femoral vessel development and peripheral cannulation are time-consuming procedures. The restricted operative field also results in longer CPB and ACC times. Therefore, we used lower target body temperatures in the MICS group for major organ protection during the longer procedure. There were no significant differences in postoperative morbidities and mortalities. Re-intervention due to residual defects is an important issue, but there were no residual defects or re-interventions in either group. Because ASD closure embraces a very low level of overall risk, we think that the absence of a marked difference paradoxically reflects the stable implementation of ASD closure using MICS. There was no conversion to full sternotomy in the MICS group, which means there was no failure of the minimally invasive procedure. There were also no femoral cannulation site complications, such as lymphocele, wound infection, or pseudoaneurysm, in the MICS group. These results suggest that there were no additional complications following the peripheral cannulation procedure. There was one case of hospital mortality in the CMS group. A 64-year-old woman with chronic renal failure underwent ASD closure and intraoperative hemodialysis catheter insertion via the femoral vein. Vascular injury and intra-abdominal bleeding occurred during catheter insertion. Hematoma evacuation and bleeding control were performed on postoperative day 5. However, ischemic colitis occurred, and the patient died after a long duration of conservative management. Preoperative characteristics revealed that the MICS group was younger and included more female patients than the CMS group, which reflects the fact that young females are more concerned about cosmetics. They especially dislike median sternotomy, which creates scars that are easily visible in the neckline. Naturally, MICS was performed to satisfy the demand for smaller invisible incision. Finally, patients in the MICS group were satisfied with their small incision and favorable postoperative outcomes. The limitations of this study are its retrospective nature and small population. To overcome selection bias, propensity score matching was applied. But the matching left only 11 patients in each group, therefore further comparison could not be made. Because we do not bring patients with excellent outcomes back for follow-up in our outpatient clinic several years after surgery, we cannot collect data on cosmetic satisfaction from all patients. Therefore, objective and subjective parameters, such as a visual analogue pain scale, a satisfaction questionnaire, or an exercise test, are absent in this study. Finally, data related to ASD severity, such as Qp/Qs, pulmonary artery systolic pressure, and ASD size, were not compared between groups, because cardiac catheterization was not performed in every patient, and ASD size was not measured in every patient. In conclusion, MICS via right anterolateral thoracotomy is an alternative choice for ASD closure. The results demonstrated similar morbidity and mortality between groups, and favored MICS in chest tube drainage in the first 24 hours.
  14 in total

1.  Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years.

Authors:  J G Murphy; B J Gersh; M D McGoon; D D Mair; C J Porter; D M Ilstrup; D C McGoon; F J Puga; J W Kirklin; G K Danielson
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

2.  Minimally invasive repair of atrial septal defects.

Authors:  M D Black; R M Freedom
Journal:  Ann Thorac Surg       Date:  1998-03       Impact factor: 4.330

3.  Different approaches for minimally invasive closure of atrial septal defects.

Authors:  J T Cremer; A Böning; M B Anssar; P Y Kim; K Pethig; W Harringer; A Haverich
Journal:  Ann Thorac Surg       Date:  1999-06       Impact factor: 4.330

4.  Clinical outcomes of minimally invasive endoscopic and conventional sternotomy approaches for atrial septal defect repair.

Authors:  Michael W A Chu; Katie L Losenno; Stephanie A Fox; Corey Adams; Hamad Al-Habib; Ray Guo; Alan H Menkis; Bob Kiaii
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

5.  Repair of atrial septal defect through a right posterolateral thoracotomy: a cosmetic approach for female patients.

Authors:  N Yoshimura; M Yamaguchi; Y Oshima; S Oka; Y Ootaki; M Yoshida
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

6.  Minimally invasive video-assisted surgical closure of atrial septal defects: a safe approach.

Authors:  Anna Sabate Rotes; Harold M Burkhart; Rakesh M Suri; Martha Grogan; Nathaniel W Taggart; Zhuo Li; Hartzell V Schaff; Joseph A Dearani
Journal:  World J Pediatr Congenit Heart Surg       Date:  2014-10

7.  Safety and efficacy of minimally invasive atrial septal defect closure.

Authors:  William H Ryan; Jorge Cheirif; Todd M Dewey; Syma L Prince; Michael J Mack
Journal:  Ann Thorac Surg       Date:  2003-05       Impact factor: 4.330

8.  Operation for atrial septal defect through a right anterolateral thoracotomy: current outcome.

Authors:  M Massetti; G Babatasi; A Rossi; E Neri; S Bhoyroo; S Zitouni; P Maragnes; A Khayat
Journal:  Ann Thorac Surg       Date:  1996-10       Impact factor: 4.330

9.  Atrial septal defect closure: comparison of vertical axillary minithoracotomy and median sternotomy.

Authors:  Huseyin Hakan Poyrazoglu; Mustafa Kemal Avsar; Serafettin Demir; Zeynep Karakaya; Tayfun Güler; Funda Tor
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-10-04

10.  Surgical Outcomes of Congenital Atrial Septal Defect Using da VinciTM Surgical Robot System.

Authors:  Ji Eon Kim; Sung-Ho Jung; Gwan Sic Kim; Joon Bum Kim; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-04-09
View more
  7 in total

1.  Three-port totally endoscopic repair vs conventional median sternotomy for atrial septal defect.

Authors:  Junji Yanagisawa; Atsuo Maekawa; Sadanari Sawaki; Masayoshi Tokoro; Takahiro Ozeki; Mamoru Orii; Toshiyuki Saiga; Toshiaki Ito
Journal:  Surg Today       Date:  2018-09-20       Impact factor: 2.549

2.  Right mini-thoracotomy approach reduces hospital stay and transfusion of mitral or tricuspid valve reoperation with non-inferior efficacy: evidence from propensity-matched study.

Authors:  Qing Wang; Xiaofei Xue; Jie Yang; Qian Yang; Pei Wang; Liaoyuan Wang; Peng Zhang; Suyu Wang; Jing Wang; Jibin Xu; Jian Xiao; Zhinong Wang
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

3.  Triport periareolar thoracoscopic surgery versus right minithoracotomy for repairing atrial septal defect in adults.

Authors:  Xiang-Xiang Zheng; Ze-Yu Wang; Lu-Yao Ma; Hong- Liu; Huan- Liu; Jian-Wei Qin; Yong-Feng Shao
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-01-22

4.  Standard median sternotomy, right minithoracotomy, totally thoracoscopic surgery, percutaneous closure, and transthoracic closure for atrial septal defects in children: A protocol for a network meta-analysis.

Authors:  Kang Yi; Xujian Guo; Tao You; Yunfang Wang; Fan Ding; Xiaodong Hou; Li Zhou
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  Minimally invasive tricuspid valve surgery and concomitant MAZE procedure with closure of LA appendage through an ASD.

Authors:  Guohao Chang; Giap Swee Kang; Christos George Alexiou; Theodoros Kofidis
Journal:  Clin Case Rep       Date:  2020-11-11

6.  Clinical outcomes of a combined transcatheter and minimally invasive atrial septal defect repair program using a 'Heart Team' approach.

Authors:  Shahrukh N Bakar; Daniel J P Burns; Pantelis Diamantouros; Kumar Sridhar; Bob Kiaii; Michael W A Chu
Journal:  J Cardiothorac Surg       Date:  2018-01-18       Impact factor: 1.637

7.  Minimally invasive versus transcatheter closure of secundum atrial septal defects: a systematic review and meta-analysis.

Authors:  Esther Goh; Haya Mohammed; Mohammad Yusuf Salmasi; Samantha Ho; Umberto Benedetto; Massimo Caputo; Gianni Angelini; Hunaid A Vohra
Journal:  Perfusion       Date:  2021-06-10       Impact factor: 1.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.